Instruction for use: Fluoxetine

Dosage form: capsules

Active substance: Fluoxetine*

ATX

N06AB03 Fluoxetin

Pharmacological groups:

Antidepressant

The nosological classification (ICD-10)

F32 Depressive episode: Adynamic subdepression; Astheno-adynamic subdepressive states; Asthenoadressive disorder; Astheno-depressive disorder; Asthenodepressive state; Astheno-depressive state; Major Depressive Disorder; Vyaloapatichesky depression with retardation; Double Depression; Depressive pseudodement; Depressive illness; Depressive mood disorder; Depressive disorder; Depressive mood disorder; Depressive state; Depressive disorders; Depressive syndrome; Depressive syndrome larviated; Depressive syndrome in psychoses; Depressed masks; Depression; Depression Depletion; Depression with the phenomena of inhibition within the framework of cyclothymia; Depression is smiling; Involutional depression; Involutionary melancholy; Involutional depression; Manic-depressive disorder; Masked Depression; Melancholic Attack; Neurotic depression; Neurotic depression; Shallow Depression; Organic depression; Organic depressive syndrome; Simple depression; Simple melancholic syndrome; Psychogenic depression; Reactive depression; Reactive depression with moderate psychopathological symptoms; Reactive depressive states; Reactive depression; Recurrent depression; Seasonal depressive syndrome; Severostatic depression; Senile Depression; Symptomatic Depression; Somatogenic depression; Cyclotymic depression; Exogenous depression; Endogenous depression; Endogenous Depressive Conditions; Endogenous Depression; Endogenous depressive syndrome

F33 Recurrent depressive disorder: Major depressive disorder; Secondary depression; Double Depression; Depressive pseudodement; Depressive mood disorder; Depressive disorder; Depressive mood disorder; Depressive state; Depressive syndrome; Depressed masks; Depression; Depression is smiling; Involutional depression; Involutional depression; Masked Depression; Melancholic Attack; Reactive depression; Reactive depression with moderate psychopathological symptoms; Reactive depressive states; Exogenous depression; Endogenous depression; Endogenous Depressive Conditions; Endogenous Depression; Endogenous depressive syndrome

F42 Obsessive-compulsive disorder: Obsessive-compulsive syndrome; Obsessive compulsive states; Obsessive-compulsive syndrome; The Obsession Syndrome; The obsession neurosis; Obsessive-compulsive neurosis; Obsessions

F50.2 Nervous Bulimia: Bulimic Neurosis; Bulimia; Wolf hunger; Kinorexia

Composition

Capsules 1 caps.

active substance:

fluoxetine hydrochloride 11.2 mg

(corresponding to 10 mg fluoxetine)

fluoxetine hydrochloride 22.4 mg

(corresponding to 20 mg of fluoxetine)

auxiliary substances: lactose monohydrate (milk sugar) - 30.8 / 61.6 mg; MCC - 16.1 / 32.2 mg; silicon dioxide colloid (aerosil) - 0.15 / 0.3 mg; magnesium stearate - 0.6 / 1.2 mg; talc - 1,15 / 2,3 mg

capsules, 10 mg: gelatin - 36.44 mg; titanium dioxide - 1.52 mg; indigocarmine - 0.04 mg

capsules, 20 mg: gelatin - 36.44 mg; titanium dioxide - 1.52 mg; dye azorubin - 0.03 mg; the coloring powder "Ponso 4R" - 0.01 mg; dye blue patented - 0.05 mg; dye diamond black - 0.06 mg

Pharmachologic effect

Pharmacological action - antidepressant, anorexigenic.

Dosing and Administration

Inside, at any time, regardless of food intake.

Depressive state. The initial dose is 20 mg / day in the morning, regardless of food intake. If necessary, the dose may be increased to 40-60 mg / day, divided into 2-3 doses (20 mg / day weekly). The maximum daily dose is 80 mg in 2-3 divided doses.

The clinical effect develops 1-2 weeks after the start of treatment, in some patients it can be achieved later.

Obsessive-compulsive disorder. The recommended dose is 20-60 mg / day.

Bulimic neurosis. The drug is used in a daily dose of 60 mg in 2-3 divided doses.

The use of the drug by patients of different ages. There are no data on dose changes depending on age. Begin the treatment of elderly patients with a dose of 20 mg / day.

Accompanying illnesses. Assign fluoxetine to patients with impaired liver or kidney function is recommended with the use of low doses and lengthening the interval between doses.

Release form

Capsules, 10 mg and 20 mg. 10 pieces. in the outline cell pack. 1, 2, 3, 4 or 5 contour mesh packages in a pack of cardboard.

Conditions of leave from pharmacies

On prescription.

Storage conditions for Fluoxetine

In a dry, the dark place at a temperature of no higher than 25 ° C.

Keep out of the reach of children.

Shelf life of Fluoxetine

3 years.

Do not use after the expiry date printed on the package.